<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药融投资 | wechat-feeds</title><link>http://Mzg5OTA1NDgzMg.favicon.privacyhide.com/favicon.ico</link><description>医药行业</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 19 May 2021 10:22:27 +0800</pubDate><image><url>http://Mzg5OTA1NDgzMg.favicon.privacyhide.com/favicon.ico</url><title>药融投资 | wechat-feeds</title><link>http://Mzg5OTA1NDgzMg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>勃林格殷格翰，全球最富有家族之一创立的药企</title><link>https://mp.weixin.qq.com/s/wNTOWwJ4PLs5wJfTsS_d8A</link><description></description><content:encoded><![CDATA[勃林格殷格翰，全球最富有家族之一创立的药企]]></content:encoded><pubDate>Wed, 19 May 2021 09:33:37 +0800</pubDate></item><item><title>十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会</title><link>https://mp.weixin.qq.com/s/D9WQMKHYWKUWkCt_wpzxiQ</link><description></description><content:encoded><![CDATA[十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会]]></content:encoded><pubDate>Wed, 19 May 2021 09:33:37 +0800</pubDate></item><item><title>【重磅】中国AI新药合作大会来袭</title><link>https://mp.weixin.qq.com/s/ZmdjQ2eLghslHhJZ36sNPw</link><description></description><content:encoded><![CDATA[【重磅】中国AI新药合作大会来袭]]></content:encoded><pubDate>Wed, 19 May 2021 09:33:37 +0800</pubDate></item><item><title>亚盛医药（6855.HK）获纳入MSCI中国小型指数成份股</title><link>https://mp.weixin.qq.com/s/TkDjwPoxFcjVx6VVlI_UrA</link><description></description><content:encoded><![CDATA[亚盛医药（6855.HK）获纳入MSCI中国小型指数成份股]]></content:encoded><pubDate>Thu, 13 May 2021 10:21:21 +0800</pubDate></item><item><title>大咖云集共话热点 ，这个高端制剂/改良新药峰会不一般！</title><link>https://mp.weixin.qq.com/s/qtrAY3aeMUWMAcVLNMTWJw</link><description></description><content:encoded><![CDATA[大咖云集共话热点 ，这个高端制剂/改良新药峰会不一般！]]></content:encoded><pubDate>Thu, 13 May 2021 10:21:21 +0800</pubDate></item><item><title>重磅！健信生物完成A轮融资，加速PD-1后时代双抗产品开发</title><link>https://mp.weixin.qq.com/s/o7y4q1uOmp4W7Ml2iAzHMg</link><description></description><content:encoded><![CDATA[重磅！健信生物完成A轮融资，加速PD-1后时代双抗产品开发]]></content:encoded><pubDate>Thu, 13 May 2021 10:21:21 +0800</pubDate></item><item><title>就在后天！大湾区(广州)生物医药创新者峰会：千名医药人将共聚一堂</title><link>https://mp.weixin.qq.com/s/blhipDg5KdcMdE2o8Earcw</link><description></description><content:encoded><![CDATA[就在后天！大湾区(广州)生物医药创新者峰会：千名医药人将共聚一堂]]></content:encoded><pubDate>Sun, 09 May 2021 16:51:50 +0800</pubDate></item><item><title>大咖云集共话热点 ，这个高端制剂/改良新药峰会不一般！</title><link>https://mp.weixin.qq.com/s/a0qhBy_oJH3B62GytLv8nQ</link><description></description><content:encoded><![CDATA[大咖云集共话热点 ，这个高端制剂/改良新药峰会不一般！]]></content:encoded><pubDate>Sun, 09 May 2021 16:51:50 +0800</pubDate></item><item><title>大湾区新药峰会：瞄准创新药项目，高潜力企业已就位！</title><link>https://mp.weixin.qq.com/s/W1db_qO9Zl707mG4meIMuQ</link><description></description><content:encoded><![CDATA[大湾区新药峰会：瞄准创新药项目，高潜力企业已就位！]]></content:encoded><pubDate>Sun, 09 May 2021 16:51:50 +0800</pubDate></item><item><title>大湾区(广州)生物医药创新者峰会报名通道关闭：千名医药人将共聚一堂</title><link>https://mp.weixin.qq.com/s/CH7ND3JUhM3NLbhIbUPG2g</link><description></description><content:encoded><![CDATA[大湾区(广州)生物医药创新者峰会报名通道关闭：千名医药人将共聚一堂]]></content:encoded><pubDate>Fri, 07 May 2021 13:36:08 +0800</pubDate></item><item><title>为什么要关注改良型新药的研发？</title><link>https://mp.weixin.qq.com/s/OxaqRWfk38uo2i4NDxJJYg</link><description></description><content:encoded><![CDATA[为什么要关注改良型新药的研发？]]></content:encoded><pubDate>Fri, 07 May 2021 13:36:08 +0800</pubDate></item><item><title>董晨院士正式担任上海市免疫治疗创新研究院</title><link>https://mp.weixin.qq.com/s/W_nuhOFiWKgZgGfkffzQHg</link><description></description><content:encoded><![CDATA[董晨院士正式担任上海市免疫治疗创新研究院]]></content:encoded><pubDate>Fri, 30 Apr 2021 11:08:10 +0800</pubDate></item><item><title>临床CRO:百试达医药接受上市辅导</title><link>https://mp.weixin.qq.com/s/WKRlE2HA4LjnBrAnoBj25A</link><description></description><content:encoded><![CDATA[临床CRO:百试达医药接受上市辅导]]></content:encoded><pubDate>Thu, 29 Apr 2021 12:44:08 +0800</pubDate></item><item><title>大热门：一文概览抗体偶联药物（ADC）及其研发进展</title><link>https://mp.weixin.qq.com/s/NBlc4dW9UAZfNCiBWKkf6w</link><description></description><content:encoded><![CDATA[大热门：一文概览抗体偶联药物（ADC）及其研发进展]]></content:encoded><pubDate>Thu, 29 Apr 2021 12:44:08 +0800</pubDate></item><item><title>API+CDMO:美诺华药业连续三天涨停，原因是？</title><link>https://mp.weixin.qq.com/s/lpNxOxW9-ab_-JtCDxqF4Q</link><description></description><content:encoded><![CDATA[API+CDMO:美诺华药业连续三天涨停，原因是？]]></content:encoded><pubDate>Mon, 26 Apr 2021 15:10:05 +0800</pubDate></item><item><title>国内：这些药企在/目标做first in class/first in indication新药</title><link>https://mp.weixin.qq.com/s/W3n1mCowZse_aye5FuP2oQ</link><description></description><content:encoded><![CDATA[国内：这些药企在/目标做first in class/first in indication新药]]></content:encoded><pubDate>Mon, 26 Apr 2021 15:10:05 +0800</pubDate></item><item><title>重磅：康弘终于支付房健民等2.7亿康柏西普相关费用</title><link>https://mp.weixin.qq.com/s/9t0Vrwl4eWJljBPqZjB2Iw</link><description></description><content:encoded><![CDATA[重磅：康弘终于支付房健民等2.7亿康柏西普相关费用]]></content:encoded><pubDate>Mon, 26 Apr 2021 14:59:53 +0800</pubDate></item><item><title>AI+制药如此火热？哪些企业率先将候选分子推向临床？</title><link>https://mp.weixin.qq.com/s/dGGGONgsP3EUIiIL_5cvEA</link><description></description><content:encoded><![CDATA[AI+制药如此火热？哪些企业率先将候选分子推向临床？]]></content:encoded><pubDate>Mon, 26 Apr 2021 14:59:53 +0800</pubDate></item><item><title>抓住风口 | 重庆创新制剂及改良型新药研发峰会报名通道开启</title><link>https://mp.weixin.qq.com/s/SSrxPTfNhmQ_ypynQHyM9A</link><description></description><content:encoded><![CDATA[抓住风口 | 重庆创新制剂及改良型新药研发峰会报名通道开启]]></content:encoded><pubDate>Thu, 15 Apr 2021 08:28:58 +0800</pubDate></item><item><title>大湾区(广州)生物医药创新者峰会：5月11-12日启航</title><link>https://mp.weixin.qq.com/s/kWbld93gvA_g3OH_jIGfKw</link><description></description><content:encoded><![CDATA[大湾区(广州)生物医药创新者峰会：5月11-12日启航]]></content:encoded><pubDate>Thu, 15 Apr 2021 08:28:58 +0800</pubDate></item></channel></rss>